JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
72 hedge funds and large institutions have $195M invested in Jounce Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
28% less capital invested
Capital invested by funds: $270M → $195M (-$75.3M)
Holders
72
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$12M | |
| 2 | +$2.8M | |
| 3 | +$2.36M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.98M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$1.46M |
Top Sellers
| 1 | -$5.68M | |
| 2 | -$3.1M | |
| 3 | -$2.2M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$2.01M |
| 5 |
Millennium Management
New York
|
-$1.25M |